Efficacy and Safety of Bimekizumab in Japanese Patients with Generalised Pustular Psoriasis and Erythrodermic Psoriasis: 3-Year Results from BE BRIGHT, a Multicentre, Open-Label, Phase 3 Study

20250 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov identifier, NCT03598790.

Responsible consumption and production

Published in: Dermatology and Therapy

Volume 15, Issue 10, pp. 2947-2966

Field-Weighted Citation Impact: 0.00